NEOG has surged as Food Safety growth, product launches and 3M integration support higher fiscal 2026 revenue guidance despite cost pressures.

Neogen has surged over the past year as product launches and 3M Food Safety integration progress, but debt levels and competition remain key concerns.

Neogen Corporation (NASDAQ: NEOG), an innovative leader in food and animal safety solutions, today announced the expanded availability of FIFRA* Section 2(ee)

LANSING, Mich.--(BUSINESS WIRE)--Neogen Corporation (NASDAQ: NEOG), an innovative leader in food and animal safety solutions, today announced the expanded availability of FIFRA* Section 2(ee) recommendations for the use of Prozap® Insectrin X Concentrate and Prozap® Screw Worm and Ear Tick Aerosol as part of New World Screwworm (NWS) response efforts. These recommendations provide ranchers, livestock producers, and horse owners with an additional option to support fly management efforts. In Tex.

LANSING, Mich.--(BUSINESS WIRE)--Neogen® Corporation (NASDAQ: NEOG), an innovative leader in food safety solutions, today announced that its Molecular Detection Assay - Listeria Right Now™ rapid environmental monitoring test has received AOAC® Performance Tested Methods℠ (PTM) certification (No. 042604), validating the test's performance for the enrichment-free detection of viable and non-viable Listeria species on stainless steel surfaces. The technology allows technicians to perform the assay.

Neogen beats Q3 earnings and revenue estimates, but margins slump and stock drops nearly 3% after results.

U.S. stocks traded higher midway through trading, with the Dow Jones index gaining more than 350 points on Thursday.

Neogen Corporation (NEOG) Q3 2026 Earnings Call Transcript

Although the revenue and EPS for Neogen (NEOG) give a sense of how its business performed in the quarter ended February 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Neogen (NEOG) came out with quarterly earnings of $0.09 per share, beating the Zacks Consensus Estimate of $0.04 per share. This compares to earnings of $0.1 per share a year ago.